$ loading_
Aggregate clinical, publication, regulatory, and market signals to audit drug-ticker pairs.
Copy the install command and let the AI configure it · recommended for beginners
No copy-paste install info for "biopharma-catalyst-mcp" yet — see the docs or source repo.
Use biopharma-catalyst-mcp to audit the relationship between ticker XBIO and candidate drug ABC-101. Summarize key signals from ClinicalTrials.gov, PubMed, SEC EDGAR, openFDA, and Yahoo Finance, then provide a forensic verdict and key risks.
An audit report combining multi-source evidence, with key findings, evidence summaries, risk flags, and a final verdict.
Check whether drug DEF-202 has verifiable catalyst events within the next 12 months. Use trial progress, publications, regulatory records, and company disclosures to assess credibility and potential market impact.
A catalyst event list with credibility assessments, timeline, evidence sources, and potential impact analysis.
Run quick diligence on ticker NBIO and its lead drug pipeline. Identify the most important clinical, academic, regulatory, and financial signals, and note which ones support or weaken the investment narrative.
A diligence summary for research evaluation, highlighting positive and negative signals, supporting evidence, and follow-up watchpoints.
Query biomedical and pharma APIs for trials, drugs, molecules, and literature.
Access biomedical APIs to explore genes, drugs, diseases, and clinical research.
Retrieve verified literature metadata, citations, and audit manuscript citation accuracy.
Search compound-target links, rank bioactivity, and find drug mechanisms and indications.
Search SEC filings in real time and extract financial and insider-trading insights.
Access FDA and ClinicalTrials.gov data for compliance, safety monitoring, and regulatory due diligence.